GALECTIN THERAPEUTICS INC. (GALT) Net income 2016–2025
GALECTIN THERAPEUTICS INC. (GALT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$30.8MFY2025 · since FY2016: -$21.4M → -$30.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$30.8M | +34.5% |
| FY2024 | -$47.0M | -14.6% |
| FY2023 | -$41.1M | -5.9% |
| FY2022 | -$38.8M | -27.0% |
| FY2021 | -$30.5M | -30.1% |
| FY2020 | -$23.5M | -76.5% |
| FY2019 | -$13.3M | +4.4% |
| FY2018 | -$13.9M | +14.4% |
| FY2017 | -$16.2M | +24.3% |
| FY2016 | -$21.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GALT financial trends
GALT RevenueGALT Net marginGALT Gross profitGALT Gross marginGALT Operating incomeGALT Operating marginGALT Operating cash flowGALT Free cash flowGALT Capital expendituresGALT Return on equityGALT Stock buybacksGALT Dividends paidGALT Total assetsGALT Total liabilitiesGALT Shareholders’ equityGALT overview →